期刊文献+

结核分枝杆菌Ag85A基因DNA疫苗的构建和免疫原性研究 被引量:3

Construction and immunogenicity of DNA vaccine of Ag85A gene of mycobacterium tuberculosis
下载PDF
导出
摘要 目的 构建编码结核分枝杆菌蛋白Ag85A基因为基础的DNA疫苗。 方法 采用聚合酶链反应从结核杆菌H37Rv株基因组中 ,扩增出分泌蛋白Ag85A成熟蛋白的编码基因 ,用限制性内切酶消化后 ,插入克隆载体 pGEM TEasy中。经酶切鉴定与序列测定证实后 ,以亚克隆法构建于真核表达载体 pcDNA3.1的相应酶切位点。重组质粒肌注免疫小鼠 ,4周后用ELISA法检测抗体滴度。结果 结核分枝杆菌H37Rv株Ag85A成熟蛋白的编码基因经序列测定证实无突变 ;经BamHⅠ和EcoRⅠ双酶切鉴定证实克隆基因正确插入载体 pcDNA3.1。ELISA法检测几何平均滴度为 1∶10 0 0。结论 以Ag85A成熟蛋白的编码基因为基础的DNA疫苗的成功构建和表达 。 Objective To construct DNA vaccine based on Ag85A gene of mycobacterium tuberculosis. Methods The gene encoding Ag85A mature protein was amplified by polymerase chain reaction (PCR) from genome of mycobacterium tuberculosis H37Rv strain, and was inserted into cloning vector pGEM-T Easy after restriction endonuclease digestion. Gene fragment encoding Ag85A mature protein was correctly inserted into the vector, which was confirmed by partial nucleotide sequencing and restriction endonuclease digestion, and then was subcloned to the same sites of eukaryotic expressing vector pcDNA3.1. When the mice were vaccinated with recombinant eukaryotic expressing vector 4 weeks later, titers of serum antibody against Ag85A were detected by ELISA.Results The nucleotide sequencing of the gene encoding Ag85A mature form of mycobacterium tuberculosis H37Rv strain was identical and there were no undesired mutations, the cloning gene was correctly inserted into the vector pcDNA3.1 as confirmed by restriction endonuclease digestion of BamHI and EcoRI. Mean geometric antibody titer of Ag85A was 1∶1 000 by ELISA. Conclusion DNA vaccine constructed and expressed successfully based on the gene encoding Ag85A mature protein of mycobacterium tuberculosis lays a foundation for further research into the prevention and treatment of tuberculosis and carcinoma.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2003年第5期416-419,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 西安交通大学行动计划培植项目 (PZ0 87)
关键词 结核分枝杆菌 Ag85A基因 DNA疫苗 结核病 mycobacterium tuberculosis Ag85A DNA vaccine
  • 相关文献

参考文献12

  • 1吴雪琼.结核病DNA疫苗的研究进展[J].中华结核和呼吸杂志,2000,23(4):253-254. 被引量:6
  • 2李家贵,陈忠.浅表性膀胱肿瘤术后膀胱灌注治疗方案的选择[J].临床泌尿外科杂志,2001,16(6):243-244. 被引量:37
  • 3范雄林,徐志凯,李元,薛莹,张芳琳,李别虎,白光春.结核分枝杆菌Ag85B成熟蛋白基因免疫[J].第四军医大学学报,2001,22(14):1282-1286. 被引量:22
  • 4李晖,钟森,张建军.分枝杆菌Ag85研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),2001,24(2):58-61. 被引量:3
  • 5Baldwin SL, D'Souza C, Roberts AD, et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J].Infect Immun,1998,66(6) :2951--2959.
  • 6Rishmann P, Dcsgrandchamps F, Malavaud B, et al. BCG intravesical instillations: recommendations for side-effects management [J]. Eur Urol ,2000,37(suppl 1) : 33--36.
  • 7Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo [J]. Science, 1990,247(4949 Pt 1):1465--1468.
  • 8Tanghe A, Content J, Van Vooren JP, et al. Protective efficacy of a DNA vaccine encoding antigen 85A from mycobacterium bovis BCG against buruli ulcer [J]. Infect Immun,2001,69 (9) :5403--5411.
  • 9Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual [M]. 2nd. New York: Cold Spring Harbor Laboratory Press, 1992,16--69.
  • 10Zlotta AR,Van Vooren JP,Denis O, et al. What are the immunologically active components of bacilli Calmette-Guerin in therapy of superficial bladder cancer [J]. Int J Cancer, 2000,87(6):844--852.

二级参考文献32

  • 1痔临床诊治指南(2006版)[J].中华胃肠外科杂志,2006,9(5):461-463. 被引量:2119
  • 2Lim JH et al. Infection and Immunity . 1999
  • 3Ulmer JB et al. Vaccine . 1997
  • 4Content J et al. Infection and Immunity . 1991
  • 5Harth G et al. Infection and Immunity . 1996
  • 6Abou-Zeid C et al. Infection and Immunity . 1988
  • 7Bentley-Hibbert SI et al. Infection and Immunity . 1999
  • 8Roche PW et al. Infection and Immunity . 1994
  • 9Huygen K et al. Nature Medicine . 1996
  • 10Denis O et al. Infection and Immunity . 1998

共引文献64

同被引文献22

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部